Items per page
1 - 40 of 40
Title Published in Access level OA Policy Year Views Downloads
Self-assembled proteomimetic (SAP) with antibody-like binding from short PNA–peptide conjugatesProceedings of the National Academy of Sciences of the United States of America
accessLevelPublic
2025 11 8
One-year longitudinal study of antibody profiles in children : MIS-C versus children with uncomplicated COVID-19The Pediatric infectious disease journal
accessLevelPublic
2024 32 36
SARS-CoV-2 viral load and shedding kineticsNature reviews. Microbiology
accessLevelPublic
2023 160 81
Clinical sensitivity and specificity of a high-throughput microfluidic nano-immunoassay combined with capillary blood microsampling for the identification of anti-SARS-CoV-2 Spike IgG serostatusPloS one
accessLevelPublic
2023 88 26
SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responsesEBioMedicine
accessLevelPublic
2023 69 69
Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19Frontiers in immunology
accessLevelPublic
2023 159 23
Influence of circadian clocks on adaptive immunity and vaccination responsesNature communications
accessLevelPublic
2023 238 48
Determinants of adolescents' Health-Related Quality of Life and psychological distress during the COVID-19 pandemicPloS one
accessLevelPublic
2022 135 86
Applying mixture model methods to SARS-CoV-2 serosurvey data from GenevaEpidemics
accessLevelPublic
2022 162 53
Persistent symptoms after SARS-CoV-2 infection in children: a cross-sectional population-based serological studyBMJ open
accessLevelPublic
2022 93 25
Transient elevation of humoral responses against apolipoprotein A-1 following COVID-19 and its association with symptoms persistence90th EAS (European Atherosclerosis Society) Congress
2022 65 0
Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not BetaNature
accessLevelPublic
2022 1,399 191
Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistenceEuropean journal of clinical investigation
accessLevelPublic
2022 376 88
COVID-19-related school disruptions and well-being of children and adolescents in GenevaJournal of paediatrics and child health
accessLevelPublic
2022 82 61
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCsNature communications
accessLevelPublic
2022 241 125
Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2Nature medicine
accessLevelPublic
2022 219 73
Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 – A Comprehensive AnalysisFrontiers in immunology
accessLevelPublic
2022 154 91
Insights into household transmission of SARS-CoV-2 from a population-based serological surveyNature Communications
accessLevelPublic
2021 368 129
SARS-COV2- infection as a trigger of humoral response against apolipoprotein A-1EAS Congress 2021
2021 286 38
Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunityCell reports
accessLevelPublic
2021 367 189
Clinical, virological and immunological features of a mild case of SARS-CoV-2 re-infectionClinical Microbiology and Infection
accessLevelPublic
2021 479 273
Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of SymptomsJournal of clinical immunology
accessLevelPublic
2021 258 92
Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroconversion and occupational exposure of employees at a Swiss university hospital: A large longitudinal cohort studyInfection Control and Hospital Epidemiology
accessLevelPublic
2021 269 157
Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillanceClinical Microbiology and Infection
accessLevelPublic
2021 249 208
Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal studyClinical Microbiology and Infection
accessLevelPublic
2021 355 171
Waning antibodies to SARS-CoV-2 - Don't panicThe Lancet Regional Health. Europe
accessLevelPublic
2021 144 60
Sero-molecular epidemiology of hepatitis E virus in pigs and human contacts in GhanaOne Health Outlook
accessLevelPublic
2021 212 78
SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1European Journal of Clinical Investigation
accessLevelPublic
2021 346 222
A high-throughput microfluidic nanoimmunoassay for detecting anti–SARS-CoV-2 antibodies in serum or ultralow-volume blood samplesProceedings of the National Academy of Sciences
accessLevelPublic
2021 268 121
Post-exposure Lopinavir-Ritonavir Prophylaxis versus Surveillance for Individuals Exposed to SARS-CoV-2: The COPEP Pragmatic Open-Label, Cluster Randomized TrialEClinicalMedicine
accessLevelPublic
2021 589 115
Head-to-head evaluation of five automated SARS-CoV-2 serology immunoassays in various prevalence settingsJournal of Clinical Medicine
accessLevelPublic
2021 299 136
Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT)Emerging Microbes & Infections
accessLevelPublic
2020 373 134
Validation of a commercially available SARS-CoV-2 serological immunoassayClinical Microbiology and Infection
accessLevelPublic
2020 461 245
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based studyThe Lancet
accessLevelRestricted
2020 703 14
Diagnostic accuracy of Augurix COVID-19 IgG serology rapid testEuropean Journal of Clinical Investigation
accessLevelPublic
2020 403 327
Head-to-head accuracy comparison of three commercial COVID-19 IgM/IgG serology rapid testsJournal of Clinical Medicine
accessLevelPublic
2020 339 163
SARS-CoV-2 seroprevalence in COVID-19 hotspotsThe Lancet
accessLevelPublic
2020 313 87
Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: a case seriesmSphere
accessLevelPublic
2020 460 178
Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trialBMJ Open
accessLevelPublic
2020 218 96
Link of a ubiquitous human coronavirus to dromedary camelsProceedings of the National Academy of Sciences of the United States of America
accessLevelPublic
2016 164 96
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack